AI Science Tracker
EN

Enhancing Prediction of Myocardial Recovery After Coronary Revascularization: Integrating Radiomics from Myocardial Contrast Echocardiography with Machine Learning.

Department of Ultrasound, The People's Hospital of Yuhuan, Yuhuan City, Zhejiang Province, People's Republic of China.; Department of Ultrasound, Taizhou Hospital of Zhejiang Province, Linhai City, Zhejiang Province, People's Republic of China.; Department of Cardiology, The People's Hospital of Yuhuan, Yuhuan City, Zhejiang Province, People's Republic of China. · 31 May 2024 · medicine

Discovery

Enhancing Prediction of Myocardial Recovery After Coronary Revascularization: Integrating Radiomics from Myocardial Contrast Echocardiography with Machine Learning.

Source check: Source checked. Not independent scientific confirmation.

Finding: Prospective MCE radiomics in 55 revascularization patients predicted recovery in 273 dysfunctional myocardial segments; radiomics/ML were compared with MBF (AUC 0.770), and recovery was defined by follow-up wall-motion improvement. Small patient cohort. AI role: Radiomics features with machine-learning prediction models. The article appeared in International Journal Of General Medicine.

Technology: Radiomics features with machine-learning prediction models

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Radiomics features with machine-learning prediction models
Test and result
Prospective MCE radiomics in 55 revascularization patients predicted recovery in 273 dysfunctional myocardial segments; radiomics/ML were compared with MBF (AUC 0.770), and recovery was defined by follow-up wall-motion improvement. Small patient cohort.
Limitation / still unknown
The result is limited to the described dataset, cohort, experimental system, or validation design; generalization beyond that scope and downstream real-world benefit are not established. Author affiliation was not stated in the reviewed abstract or metadata.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11151281/ · https://doi.org/10.2147/ijgm.s465023 · https://europepmc.org/article/MED/38841127 · https://pubmed.ncbi.nlm.nih.gov/38841127/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.